172 related articles for article (PubMed ID: 26806555)
1. Levo-tetrahydropalmatine, a natural, mixed dopamine receptor antagonist, inhibits methamphetamine self-administration and methamphetamine-induced reinstatement.
Gong X; Yue K; Ma B; Xing J; Gan Y; Wang D; Jin G; Li C
Pharmacol Biochem Behav; 2016 May; 144():67-72. PubMed ID: 26806555
[TBL] [Abstract][Full Text] [Related]
2. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
[TBL] [Abstract][Full Text] [Related]
3. The dopamine receptor antagonist levo-tetrahydropalmatine attenuates heroin self-administration and heroin-induced reinstatement in rats.
Yue K; Ma B; Ru Q; Chen L; Gan Y; Wang D; Jin G; Li C
Pharmacol Biochem Behav; 2012 Jul; 102(1):1-5. PubMed ID: 22741173
[TBL] [Abstract][Full Text] [Related]
4. L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression.
Yun J
Phytomedicine; 2014 Sep; 21(11):1287-91. PubMed ID: 25172791
[TBL] [Abstract][Full Text] [Related]
5. Levo-tetrahydropalmatine attenuates the development and expression of methamphetamine-induced locomotor sensitization and the accompanying activation of ERK in the nucleus accumbens and caudate putamen in mice.
Zhao N; Chen Y; Zhu J; Wang L; Cao G; Dang Y; Yan C; Wang J; Chen T
Neuroscience; 2014 Jan; 258():101-10. PubMed ID: 24269936
[TBL] [Abstract][Full Text] [Related]
6. Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats.
Mantsch JR; Li SJ; Risinger R; Awad S; Katz E; Baker DA; Yang Z
Psychopharmacology (Berl); 2007 Jul; 192(4):581-91. PubMed ID: 17361394
[TBL] [Abstract][Full Text] [Related]
7. Levo-tetrahydropalmatine: A new potential medication for methamphetamine addiction and neurotoxicity.
Liu L; Liu M; Zhao W; Zhao YL; Wang Y
Exp Neurol; 2021 Oct; 344():113809. PubMed ID: 34256045
[TBL] [Abstract][Full Text] [Related]
8. Levo-tetrahydropalmatine attenuates methamphetamine reward behavior and the accompanying activation of ERK phosphorylation in mice.
Su H; Sun T; Wang X; Du Y; Zhao N; Zhu J; Yan J; Chen T; Yun K
Neurosci Lett; 2020 Jan; 714():134416. PubMed ID: 31398456
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.
Figueroa-Guzman Y; Mueller C; Vranjkovic O; Wisniewski S; Yang Z; Li SJ; Bohr C; Graf EN; Baker DA; Mantsch JR
Drug Alcohol Depend; 2011 Jul; 116(1-3):72-9. PubMed ID: 21196089
[TBL] [Abstract][Full Text] [Related]
10. Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats.
Mantsch JR; Wisniewski S; Vranjkovic O; Peters C; Becker A; Valentine A; Li SJ; Baker DA; Yang Z
Pharmacol Biochem Behav; 2010 Dec; 97(2):310-6. PubMed ID: 20816889
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of levo-tetrahydropalmatine on the methamphetamine-induced spatial memory impairment in mice.
Cao G; Zhang Y; Zhu L; Zhu J; Zhao N; Dong N; Dang Y; Chen Y; Chen T
Neurosci Lett; 2018 Apr; 672():34-39. PubMed ID: 29447954
[TBL] [Abstract][Full Text] [Related]
12. A novel dopamine D3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats.
Chen Y; Song R; Yang RF; Wu N; Li J
Eur J Pharmacol; 2014 Nov; 743():126-32. PubMed ID: 25261038
[TBL] [Abstract][Full Text] [Related]
13. L-Stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates heroin self-administration and cue-induced reinstatement in rats.
Yue K; Ma B; Chen L; Tian X; Ru Q; Gan Y; Wang D; Jin G; Li C
Neuroreport; 2014 Jan; 25(1):7-11. PubMed ID: 24145772
[TBL] [Abstract][Full Text] [Related]
14. Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
Xi ZX; Yang Z; Li SJ; Li X; Dillon C; Peng XQ; Spiller K; Gardner EL
Neuropharmacology; 2007 Nov; 53(6):771-82. PubMed ID: 17888459
[TBL] [Abstract][Full Text] [Related]
15. Levo-tetrahydropalmatine inhibits the acquisition of ketamine-induced conditioned place preference by regulating the expression of ERK and CREB phosphorylation in rats.
Du Y; Du L; Cao J; Hölscher C; Feng Y; Su H; Wang Y; Yun KM
Behav Brain Res; 2017 Jan; 317():367-373. PubMed ID: 27713001
[TBL] [Abstract][Full Text] [Related]
16. L-stepholidine, a natural dopamine receptor D1 agonist and D2 antagonist, inhibits heroin-induced reinstatement.
Ma B; Yue K; Chen L; Tian X; Ru Q; Gan Y; Wang D; Jin G; Li C
Neurosci Lett; 2014 Jan; 559():67-71. PubMed ID: 24269875
[TBL] [Abstract][Full Text] [Related]
17. l-tetrahydropalmatine reduces nicotine self-administration and reinstatement in rats.
Faison SL; Schindler CW; Goldberg SR; Wang JB
BMC Pharmacol Toxicol; 2016 Nov; 17(1):49. PubMed ID: 27817750
[TBL] [Abstract][Full Text] [Related]
18. Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.
Sushchyk S; Xi ZX; Wang JB
J Pharmacol Exp Ther; 2016 May; 357(2):248-57. PubMed ID: 26903543
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D
Liu YY; Wang TX; Zhou JC; Qu WM; Huang ZL
Psychopharmacology (Berl); 2019 Nov; 236(11):3169-3182. PubMed ID: 31172225
[TBL] [Abstract][Full Text] [Related]
20. A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.
Hiranita T; Yamamoto T; Nawata Y
Neuroscience; 2010 Jan; 165(2):300-12. PubMed ID: 19883738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
